Amarin Corp Plc (AMRN)

[sstyles]

Read this article on Novartis's $10 BN acquisition of The Medicines Company. https://biotechnologycommunity.com/md_news/novartis-strikes-9-7b-takeover-of-medicines/

Alex Denner was behind this.
Look at how much revenue it was expected The Medicine's Company drug inclisiran would generate (see below). Novartis is flushed with cash right now.

"But the deal appears to assume inclisiran will generate more than $2 billion in annual sales, according to a note to investors from Umer Raffat at Evercore ISI, because The Medicines Company splits profits from the medicine with the biotechnology firm Alnylam, which originally invented it. Inclisiran is a type of cholesterol drug called a PCSK9 inhibitor."

Does the Novartis CEO know about Amarin?
I wonder if Alex will let him know.